The COVID-19 pandemic: a threat to antimicrobial resistance containment
- PMID: 34290883
- PMCID: PMC8204817
- DOI: 10.2144/fsoa-2021-0012
The COVID-19 pandemic: a threat to antimicrobial resistance containment
Abstract
As of 23 April 2021, the outbreak of COVID-19 claimed around 150 million confirmed cases with over 3 million deaths worldwide. Yet, an even more serious but silent pandemic, that of antimicrobial resistance (AMR), is likely complicating the outcome of COVID-19 patients. This study discusses the current knowledge on the emergence of the SARS-CoV-2 and highlights the likely contribution of the COVID-19 pandemic on the escalation of AMR. COVID-19 engenders extensive antibiotic overuse and misuse, and will undoubtedly and substantially increase AMR rates worldwide. Amid the expanding COVID-19 pandemic, policymakers should consider the hidden threat of AMR much more, which may well be enhanced through improper use of antibiotics to treat patients with severe COVID-19 infection.
Keywords: COVID-19 pandemic; COVID-19 vaccines; SARS-CoV-2; antimicrobial resistance; antimicrobial stewardship.
© 2021 The authors.
Conflict of interest statement
Financial & competing interests disclosure AJ Blocker reports being a salaried employee of Evotec ID LYON, of which the main business is focused outside of the submitted work, and a member of the board of the AMR Insights Ambassador Network, which is a branch of AMR Insights, of which the company details are: AMR Insights, Keizersgracht 482, 1017 EG Amsterdam, The Netherlands; registered at The Netherlands Chamber of Commerce and Trade under number 5796317, VAT ID number: NL001114537B10. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
Figures


References
-
- World Health Organization (WHO). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). WHO, Geneva, Switzerland: (2020).
-
- O’Neill J. Antimicrobial resistance: tackling a global health crisis: initial steps. Rev. Antimicrob. Resist. (2015).
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous